Zeo Scientifix, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Zeo ScientifiX reports increased revenues driven by its PPX platform and strategic partnerships, yet faces significant net losses and going concern doubts for fiscal year 2025.
OQB
Zeo ScientifiX announces its fiscal year 2024 results, navigating regulatory challenges and focusing on clinical trials and international expansion.
OQB
Organicell Regenerative Medicine, Inc. reports a decrease in revenue for fiscal year 2023, while managing operating expenses and navigating a complex regulatory environment.